A multicomponent intervention incorporating CYP2C19 genotype-guided therapy and integrated pharmaceutical care reduces hospitalizations and improves adherence in ischemic stroke.

Zhang D et al.

NCBI PubMed Central · Papers · License: Open Access

computer science education

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 452987
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.